Earnings Call Summary | So-young International(SY.US) Q1 2024 Earnings Conference
Earnings Call Summary | So-young International(SY.US) Q1 2024 Earnings Conference
The company maintained a strong cash position, with assets totaling RMB 1.3 billion as of March 31, 2024.The following is a summary of the So-Young International Inc. (SY) Q1 2024 Earnings Call Transcript:
以下是新氧2024年第一季度業績會摘要:
Financial Performance:
金融業績：
So-Young reported Q1 total revenues of RMB318.3 million, achieving non-GAAP profitability for the quarter.
Revenue from sales of medical products and maternity services increased by 23.3% YoY, with a net loss attributable to So-Young of RMB 21.2 million.
The company maintained a strong cash position, with assets totaling RMB 1.3 billion as of March 31, 2024.
新氧第一季度總營收爲人民幣3.183億，實現非GAAP盈利。
醫療產品和孕婦服務銷售收入同比增長23.3％，而歸屬於新氧的淨虧損爲人民幣2120萬元。
截至2024年3月31日，公司資產總額爲人民幣13億元，保持強勁的現金地位。
Business Progress:
業務進展：
So-Young experienced rapid growth in new businesses and diversification of upstream product offerings.
The company made significant progress in clinic chain expansions with three new clinics in Q1 and projects a scale of 100 to 150 clinics in the next three years.
Sales of upstream medical aesthetic products increased by 80% YoY and a distribution network established across 715 institutions. For Q2 2024, projected total revenues between RMB 380 million and RMB 400 million.
新業務快速增長，上游產品供應多樣化。
公司在第一季度的診所連鎖擴張方面取得了重要進展，開設了三家新診所，並計劃在未來三年內將規模擴大到100-150家診所。
上游醫學美容產品銷售同比增長80％，並在715家機構建立了銷售網絡。透露2024年第二季度的總營收預計在人民幣3.8億元至4億元之間。
More details: So-young International IR
更多詳情：新氧國際投資者關係
Tips: This article is generated by AI. The accuracy of the content can not be fully guaranteed. For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.
提示：本文由AI生成。文章內容的準確性無法完全保證。有關更全面的詳細信息，請參閱IR網站。本文只是爲投資者提供參考，沒有任何指導或推薦建議。